• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY ULTRAFLEX¿ ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY ULTRAFLEX¿ ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513710
Device Problem Partial Blockage (1065)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/05/2015
Event Type  Injury  
Manufacturer Narrative
Although the exact patient age was not provided, the patient was reported to be over 18 years of age.Reported event of stent blocked/occluded.The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an ultraflex¿ esophageal ng stent was implanted to treat a 2-3cm malignant stricture in the lower esophagus during an esophageal stent placement procedure performed on (b)(6) 2015.According to the complainant, on two occasions sometime after the esophageal stent placement procedure, it was confirmed under fluoroscopy that food had become stuck between the ultraflex¿ esophageal ng stent and the esophageal wall.When the ultraflex¿ esophageal ng stent was visualized through the scope, the inner diameter of the stent ¿looked like a crescent moon¿ as a result of the blockage.On both occasions, after the food was endoscopically removed, the ultraflex¿ esophageal ng stent returned again into its normal shape.In the physician¿s assessment, he does not believe that the condition of the stricture would have contributed to the blockage as the stricture is at the lower part of the ultraflex¿ esophageal ng stent.This device remains implanted in the patient.There were no patient complications reported as a result of this event.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported to boston scientific corporation that an ultraflex esophageal ng stent was implanted to treat a 2-3cm malignant stricture in the lower esophagus during an esophageal stent placement procedure performed on (b)(6) 2015.According to the complainant, on two occasions sometime after the esophageal stent placement procedure, it was confirmed under fluoroscopy that food had become stuck between the ultraflex esophageal ng stent and the esophageal wall.When the ultraflex esophageal ng stent was visualized through the scope, the inner diameter of the stent "looked like a crescent moon" as a result of the blockage.On both occasions, after the food was endoscopically removed, the ultraflex esophageal ng stent returned again into its normal shape.In the physician's assessment, he does not believe that the condition of the stricture would have contributed to the blockage as the stricture is at the lower part of the ultraflex esophageal ng stent.This device remains implanted in the patient.There were no patient complications reported as a result of this event.Additional information received on (b)(4) 2015: the first occlusion was noted on (b)(6) 2015 and the second occlusion was noted on (b)(6) 2015.Additional information received on (b)(4) 2015: it was reported that the patient had passed away.The cause of death is unknown, however, the physician does not believe that the ultraflex esophageal ng stent was related to the patient's death.Additional information received on (b)(4) 2015: the physician reported that the cause of death was due to esophageal cancer.According to the physician, the ultraflex esophageal ng stent was rinsed twice on (b)(6) 2015.After the stent was rinsed the patient was able to eat a liquid food diet orally for a while.A ct scan was performed on (b)(6) 2015 and chest ascites were noted.The patient's overall condition became worse on (b)(6) 2015 and the patient died on (b)(6) 2015.In the physician's assessment, the patient died due to the progression of esophageal cancer and even if there were no device malfunction, the result would not have changed.An autopsy was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX¿ ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
nancy cutino
100 boston scientific way
marlborough, MA 01752
5086834000
MDR Report Key5036934
MDR Text Key24347753
Report Number3005099803-2015-02459
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Followup
Report Date 08/05/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/27/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date02/09/2017
Device Model NumberM00513710
Device Catalogue Number1371
Device Lot Number0017687190
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/29/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/17/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-